Showing results (21-30 of 329) with videos related to
Sort By:
Pageof 33
Clinical Lipidology|September 28, 2020
New approaches for the discovery of lipid‑related genesJoanne E Curran, Peter J Meikle, John BlangeroPharmacology & Therapeutics|May 20, 2026
Bioactive lipids in plasma and atherogenic apoB-containing lipoproteins: Effects of statins and PCSK9 inhibitors and relevance to residual cardiovascular riskM John Chapman, Patrice Therond, Peter J MeikleIslets|August 1, 2012
Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunctionEbru Boslem, Peter J Meikle, Trevor J BidenProgress in Lipid Research|April 12, 2019
Plasmalogens: A potential therapeutic target for neurodegenerative and cardiometabolic diseaseSudip Paul, Graeme I Lancaster, Peter J MeikleJournal of Alzheimer'S Disease : JAD|June 7, 2017
Lipidomic Profiles in Diabetes and DementiaKevin Huynh, Ralph N Martins, Peter J MeikleGlycobiology|January 14, 2004
Glycosaminoglycan degradation fragments in mucopolysaccharidosis IMaria Fuller, Peter J Meikle, John J HopwoodClinica Chimica Acta; International Journal of Clinical Chemistry|July 5, 2005
Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe diseaseKandiah Umapathysivam, John J Hopwood, Peter J MeikleJournal of Lipid Research|February 16, 2020
Heritability of 596 lipid species and genetic correlation with cardiovascular traits in the Busselton Family Heart StudyGemma Cadby, Phillip E Melton, Nina S McCarthy, et al.Diabetes|October 29, 2020
Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients With Type 2 DiabetesYow Keat Tham, Kaushala S Jayawardana, Zahir H Alshehry, et al.Scientific Reports|November 26, 2025
Pre-storage leucoreduction of platelet concentrates reduced biological response modifier concentrations and TRALI incidence in an in vivo sheep modelJohn-Paul Tung, Gabriela Simonova, Elise Hewlett, et al.Pageof 33